
|Articles|June 26, 2016
High-Cost Branded Drug Prescribing Trend Highlights AJPB Week in Review
Author(s)Davy James, Managing Editor
Top articles of the week from The American Journal of Pharmacy Benefits.
Advertisement
Advertisement
Advertisement
Advertisement
Trending on Pharmacy Times
1
New CKD Outcome Set Tells Pharmacists What to Measure
2
FDA Approves Zilganersen Injection, First Drug for Alexander Disease
3
AAP Issues 2026-2027 Guidance on RSV and COVID-19 Immunization
4
State Pharmacy Boards Must Step Up Against Illegal Retatrutide
5


































































































